Methotrexate an Old Drug with New Tricks

Area of Science:

• Rheumatology
• Immunology
• Pharmacology

Background:

• Methotrexate (MTX) is a primary therapy for rheumatoid arthritis (RA).
• Emerging research investigates MTX for viral-associated arthritides.
• MTX offers potent efficacy and tolerability, remaining central to RA management.

Purpose of the Study:

• To review the anti-inflammatory and immunomodulatory mechanisms of MTX.
• To elucidate the mechanisms behind MTX's toxic effects.
• To discuss the efficacy and safety of MTX in viral-related rheumatic syndromes.

Main Methods:

• Literature review of MTX mechanisms of action.
• Analysis of MTX's role in rheumatoid arthritis and viral-induced arthritis.
• Examination of MTX's impact on adenosine signaling, cytokines, reactive oxygen species, and HMGB1.

Main Results:

• MTX exhibits anti-inflammatory effects via adenosine signaling, cytokine modulation, ROS generation, and HMGB1 suppression.
• Understanding MTX's toxic effects is crucial for patient safety.
• MTX shows promise in managing viral-related rheumatic conditions, balancing benefits against potential immune suppression.

Conclusions:

• MTX is a versatile drug with established efficacy in RA and potential in viral-related arthritides.
• Further research into MTX's mechanisms and safety profile is warranted.
• MTX remains a cornerstone therapy, requiring careful consideration of its benefits and risks.